ZA923068B - Optimized tablet formulation - Google Patents
Optimized tablet formulationInfo
- Publication number
- ZA923068B ZA923068B ZA923068A ZA923068A ZA923068B ZA 923068 B ZA923068 B ZA 923068B ZA 923068 A ZA923068 A ZA 923068A ZA 923068 A ZA923068 A ZA 923068A ZA 923068 B ZA923068 B ZA 923068B
- Authority
- ZA
- South Africa
- Prior art keywords
- tablet formulation
- optimized
- optimized tablet
- formulation
- tablet
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US69274791A | 1991-04-29 | 1991-04-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA923068B true ZA923068B (en) | 1992-12-30 |
Family
ID=24781844
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA923068A ZA923068B (en) | 1991-04-29 | 1992-04-28 | Optimized tablet formulation |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP0511767A1 (xx) |
| JP (1) | JPH06157309A (xx) |
| KR (1) | KR920019340A (xx) |
| CN (1) | CN1066184A (xx) |
| AU (1) | AU1522992A (xx) |
| CA (1) | CA2067307A1 (xx) |
| CZ (1) | CZ227093A3 (xx) |
| IE (1) | IE921384A1 (xx) |
| IL (1) | IL101679A0 (xx) |
| MX (1) | MX9201969A (xx) |
| NO (1) | NO933806L (xx) |
| NZ (1) | NZ242486A (xx) |
| SK (1) | SK117793A3 (xx) |
| WO (1) | WO1992019228A1 (xx) |
| ZA (1) | ZA923068B (xx) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6406714B1 (en) | 1992-12-02 | 2002-06-18 | Merck & Co., Inc. | Dry mix formulation for bisphosphonic acids |
| WO1996018386A1 (en) * | 1994-12-14 | 1996-06-20 | Enbalt Trading Limited | Pharmaceutical tablet formulations for direct compression |
| AU724576B2 (en) * | 1996-06-24 | 2000-09-28 | Merck & Co., Inc. | A composition of enalapril and losartan |
| PL197077B1 (pl) * | 1998-12-01 | 2008-02-29 | Reddys Lab Inc Dr | Kompozycja farmaceutyczna zawierająca 5-[[4-[3-metylo-4-okso-3,4-dihydro-2-chinazolinylo]metoksy]fenylometylo]-tiazolidyno-2,4-dion lub jego sól dopuszczalną do stosowania w farmacji i sposób jej wytwarzania |
| SE9903028D0 (sv) | 1999-08-27 | 1999-08-27 | Astra Ab | New use |
| US20100074949A1 (en) | 2008-08-13 | 2010-03-25 | William Rowe | Pharmaceutical composition and administration thereof |
| EP3138566B1 (en) | 2003-11-17 | 2022-01-26 | BioMarin Pharmaceutical Inc. | Treatment of phenylketonuria with bh4 |
| BRPI0518229A (pt) | 2004-10-27 | 2008-11-04 | Daiichi Sankyo Co Ltd | composto de benzeno tendo 2 ou mais substituintes |
| WO2007026261A2 (en) * | 2005-05-18 | 2007-03-08 | Combino Pharm, S.L. | Formulations containing losartan and/or its salts |
| JP5409010B2 (ja) | 2005-12-28 | 2014-02-05 | バーテックス ファーマシューティカルズ インコーポレイテッド | Ｎ−［２，４−ビス（１，１−ジメチルエチル）−５−ヒドロキシフェニル］−１，４−ジヒドロ−４−オキソキノリン−３−カルボキサミドの固体形態 |
| JP2008208078A (ja) * | 2007-02-27 | 2008-09-11 | Takada Seiyaku Kk | 分割錠剤 |
| TR200703568A1 (tr) | 2007-05-24 | 2008-07-21 | Sanovel �La� Sanay� Ve T�Caret Anon�M ��Rket� | Valsartan formülasyonları |
| US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
| US20100120694A1 (en) | 2008-06-04 | 2010-05-13 | Synergy Pharmaceuticals, Inc. | Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders |
| US7879802B2 (en) | 2007-06-04 | 2011-02-01 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| EP2321341B1 (en) | 2008-07-16 | 2017-02-22 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders |
| US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
| CN104470518A (zh) | 2012-02-27 | 2015-03-25 | 沃泰克斯药物股份有限公司 | 药物组合物及其施用 |
| EP2970384A1 (en) | 2013-03-15 | 2016-01-20 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase and their uses |
| CA2905435A1 (en) | 2013-03-15 | 2014-09-25 | Synergy Pharmaceuticals Inc. | Compositions useful for the treatment of gastrointestinal disorders |
| BR112015030326A2 (pt) | 2013-06-05 | 2017-08-29 | Synergy Pharmaceuticals Inc | Agonistas ultrapuros de guanilato ciclase c, método de fabricar e usar os mesmos |
| CN105395509A (zh) * | 2015-12-16 | 2016-03-16 | 宁波美诺华天康药业有限公司 | 一种氯沙坦钾片的制备方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4670251A (en) * | 1984-05-30 | 1987-06-02 | Igene Biotechnology, Inc. | Microcrystalline tableting excipient derived from whey |
| US4753801A (en) * | 1985-10-25 | 1988-06-28 | Eli Lilly And Company | Sustained release tablets |
| CA1334092C (en) * | 1986-07-11 | 1995-01-24 | David John Carini | Angiotensin ii receptor blocking imidazoles |
-
1992
- 1992-04-21 SK SK1177-93A patent/SK117793A3/sk unknown
- 1992-04-21 CZ CS932270A patent/CZ227093A3/cs unknown
- 1992-04-21 EP EP92303526A patent/EP0511767A1/en not_active Withdrawn
- 1992-04-21 WO PCT/US1992/003246 patent/WO1992019228A1/en not_active Application Discontinuation
- 1992-04-23 IL IL101679A patent/IL101679A0/xx unknown
- 1992-04-24 NZ NZ242486A patent/NZ242486A/en unknown
- 1992-04-27 CA CA002067307A patent/CA2067307A1/en not_active Abandoned
- 1992-04-28 KR KR1019920007141A patent/KR920019340A/ko not_active Application Discontinuation
- 1992-04-28 ZA ZA923068A patent/ZA923068B/xx unknown
- 1992-04-28 JP JP4108255A patent/JPH06157309A/ja active Pending
- 1992-04-28 MX MX9201969A patent/MX9201969A/es unknown
- 1992-04-28 AU AU15229/92A patent/AU1522992A/en not_active Abandoned
- 1992-04-28 CN CN92103205A patent/CN1066184A/zh active Pending
- 1992-07-01 IE IE138492A patent/IE921384A1/en not_active Application Discontinuation
-
1993
- 1993-10-22 NO NO933806A patent/NO933806L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL101679A0 (en) | 1992-12-30 |
| MX9201969A (es) | 1992-11-01 |
| CZ227093A3 (en) | 1994-03-16 |
| CA2067307A1 (en) | 1992-10-30 |
| AU1522992A (en) | 1992-11-05 |
| IE921384A1 (en) | 1992-11-04 |
| WO1992019228A1 (en) | 1992-11-12 |
| EP0511767A1 (en) | 1992-11-04 |
| KR920019340A (ko) | 1992-11-19 |
| SK117793A3 (en) | 1994-05-11 |
| NZ242486A (en) | 1993-12-23 |
| CN1066184A (zh) | 1992-11-18 |
| NO933806L (no) | 1993-10-22 |
| JPH06157309A (ja) | 1994-06-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL101795A0 (en) | Pharmaceutical tablet formulations | |
| IL102777A0 (en) | Pharmaceutical combination formulation | |
| ZA923068B (en) | Optimized tablet formulation | |
| GB9114322D0 (en) | Tablet dispenser | |
| GB9114950D0 (en) | Pharmaceutical formulation | |
| GB9103824D0 (en) | Formulation | |
| GB2264383B (en) | Display-intergrated tablet | |
| GB9412897D0 (en) | Water-dispersible tablet | |
| GB9101221D0 (en) | Pharmaceuticals | |
| GB9216061D0 (en) | Pharmaceutical combination formulation | |
| AP9200422A0 (en) | Pharmaceuticals | |
| ZA933725B (en) | Tablet formulation | |
| GB2258456B (en) | Tablet dispenser | |
| CA69106S (en) | Tablet | |
| GB9108128D0 (en) | Novel formulation | |
| CA71188S (en) | Tablet | |
| ZA946797B (en) | Stabilized tablet formulation | |
| GB9323864D0 (en) | Stabilized tablet formulation | |
| CA69440S (en) | Pharmaceutical tablet | |
| GB9125953D0 (en) | Formulation | |
| GB9108281D0 (en) | Formulation | |
| GB9104946D0 (en) | Formulation | |
| GB9120675D0 (en) | Formulation | |
| CA70854S (en) | Tablet case | |
| CA70934S (en) | Tablet case |